• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Argentina: The vaccine against the flu A divides the opinion of the doctors

tetano

Editor, Senior Moderator
The application of the vaccine against the virus H1N1 keeps on sowing doubts. The campaign of the Department of Health of the Nation of vaccinating massively the population raises suspicions and certain fear about the possible undesirable effects that might take place in the organism. The doctors have positions divided at the time of the inoculation of the healthy population: some of them recommend the doses and others indicate the opposite. Of course, according to speaking about ' groups of risk ' all they coincide that they must be inoculated, although the safety of the prevention does not exist to true science.
From Europe and the United States there arise different voices that come even defenestrar to the vaccine that bought the Department of Health of the Nation to fight the virus of the flu. The clinical doctor Javier Fern?ndez is not partial to the vaccine. There are many others who think the same, but they do not dare to give his name.
Those who do not recommend the vaccine base his opinion on that of scientists as Wang Ming, the director of the Center of Control and Prevention of Illnesses of Guangzhou (China), the director of the System of Control of Infections of Geisinger Health System de Danville (Pennsylvania, the United States), Lisa Esolen, and the studies of the epidemi?logo, cardiologist and sanitarista Italian Gianni Tognoni.

Wang Ming brought children's cases that showed adverse effects after the vaccination against the virus H1N1 as the appearance of neurological damages as the syndrome of Guillain-Barr? (it provokes that the proper immune system stuffs itself to yes same).
For his{your} part, Esolen clarified that the virus muta very rapidly, for which the vaccine would not be effective, and that there are certain contents of the medicine (as the timerosal) that have mercury and that it might cause neurological disorders. Meanwhile, Tognoni was forceful and in an activity realized in March in Cordova he affirmed that ' the new preventive drug against the virus H1N1 did not work in Europe ' and that ' the defeat of the vaccine is entire '. In fact, in Europe it is neither obligatory nor massive and in Italy it was inoculated at least with 10 per cent of the population. The Italian doctor did not discard that the vaccine generates antibodies, neither but ' is verified that is frankly necessary before an illness which risks are not verified ', he said.
Basing on these investigators, Fern?ndez told that ' the vaccine that is applied did for South America and one is in phase of experimentation '.

He emphasized that ' there are not known yet what derivations it will have and meanwhile there are patients' cases with adverse effects as high fever, hiperganglionar syndrome and vomiting '.
Nevertheless, at the time of evaluating risk - benefit, Fern?ndez emphasized the need to vaccinate the groups of risk and the persons older than 65 years. ' I do not recommend a healthy adult. In fact I had to ask them not to vaccinate me ', it showed.
As for the pregnant women, the professional said that ' the topic is managing with the obstetras and they are recommending to vaccinate '.
That yes. The doubt for the application of the vaccine spreads in the population especially for the coherence absence of the doctors. Some of them recommend to place the trivalent one, others the monovalente and, in some cases, none of the two. The true thing is that the majority comes undone of the responsibility and leaves to the patients the decision to be inoculated or not. Apparently there exist economic or political pressures that silence the topic in many sectors. Moreover, doctors infect?logos recognized in the city preferred not answering to the questions of LaCapital, liberating this way any more doubts that you suspect.

For his{your} part, the secretary of the Committee of Infectolog?a of the Society of Paediatrics of Rosario, Ann Maria Chiossone, was forceful and she said that ' it is necessary to apply to the vaccine because it is the principal measurement to avoid the epidemic '.
Meanwhile, many doctors in the offices recommend ' to wait for the trivalent one ' and there are endless the mothers' waiting-lists for that it are waiting that place to his son this vaccine. Chiossone recommended ' not to wait and to inoculate the one that the State is giving ', that is the vaccine monovalente (only against the virus H1N1).
The doctor clarified that in Rosary already more than 19.000 doses were applied, and denied that adverse effects should have been observed in the population. ' Only there were seen pictures of local pain, fever, muscular pain and decay; those who recommend the trivalent one do it " for the doubts ", for if another virus appears ', he admitted.

http://www.lacapital.com.ar/contenidos/2010/05/01/noticia_0031.html
 
Back
Top Bottom